SCHEMBL6090056

SCHEMBL6090056

Oc1cccc(CNc2nc3ccccc3o2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 2/20 0.49
BCHE P06276 1/20 0.47
HDAC6 Q9UBN7 1/20 0.45
NPC1 O15118 3/20 0.44
RAB9A P51151 3/20 0.44
ALDH1A1 P00352 2/20 0.44
PKM P14618 2/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
NPSR1 Q6W5P4 2/20 0.44
GAA P10253 2/20 0.44
KDM4E B2RXH2 3/20 0.44
MAPT P10636 3/20 0.44
HTT P42858 1/20 0.44
RECQL P46063 1/20 0.44
KMT2A Q03164 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
ALOX15 P16050 1/20 0.44
NFKB1 P19838 1/20 0.44
MAPK1 P28482 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2676462 0.84 ELANE (0.65) ELANEBCHEHDAC6NPC1RAB9A
SCHEMBL21814915 0.82 ELANE (0.52) ELANEBCHEHDAC6NPC1RAB9A
SCHEMBL10370954 0.77 ELANE (0.52) ELANEBCHEHDAC6NPC1RAB9A
SCHEMBL24095278 0.76 MAOB (0.50) ALDH1A1SMN1; SMN2KDM4EMAPTHTT
SCHEMBL30583227 0.76 ALDH1A1 (0.59) ELANENPC1RAB9AALDH1A1SMN1; SMN2
SCHEMBL6542975 0.75 PPARA (0.58) ELANEHDAC6SMN1; SMN2
SCHEMBL21814778 0.74 MEN1 (0.51) NPC1RAB9AALDH1A1SMN1; SMN2NPSR1
SCHEMBL3463008 0.74 MRGPRX1 (0.52) BCHENPC1RAB9AALDH1A1PKM
SCHEMBL27733444 0.73 ELANE (0.53) ELANEBCHEHDAC6NPC1RAB9A
SCHEMBL21814817 0.72 ESR1 (0.43) ELANEBCHEHDAC6CYP3A4PIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7005440-B1 Therapeutic uses of tri-aryl acid derivatives AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2006-02-28 US disclosed
EP-1177176-A1 TRI-ARYL ACID DERIVATIVES AS PPAR RECEPTOR LIGANDS Aventis Pharma Deutschland GmbH (DE) 2002-02-06 EP disclosed
WO-2000064876-A1 TRI-ARYL ACID DERIVATIVES AS PPAR RECEPTOR LIGANDS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2000-11-02 WO disclosed